From October 19 to 21, Factor-h organized in Barranquilla, Colombia, the 2022 Huntington Latin American Conference with the presence of 35 speakers among them scientists, researchers, experts in different health fields, HD associations, patients, and families. In his Welcome conference on the 19th, Factor-h’s President and founder, neuroscientist Ignacio Muñoz Sanjuan, presented the guidelines and achievements of the non-profit organization.
Health & Disease Management
Ignacio Muñoz-Sanjuan: “We may see a Huntington’s therapy approved in 2026. It is a day for hope: while the therapy will at first be limited, access will increase in the years ahead”
24/09/2025 Ignacio Muñoz-Sanjuan, neuroscientist and founder of the non-profit Factor-H, has expressed optimism that an experimental gene therapy for Huntington’s
September 24, 2025
No Comments
English 
Español 
Português do Brasil
One Response
Contundente mensaje de Factor H a nosotros Neurólogos, sensores fundamentales de la problemática dé atención integral a los pacientes, grupos y cuidadores, puentes para la consciencia de la atencion primaria y la gobernanza.